Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
Eli Lilly and Company
Michael Dougan; Ajay Nirula; Masoud Azizad; Bharat Mocherla; Robert L Gottlieb; Peter Chen; Corey Hebert; Russell Perry; Joseph Boscia; Barry Heller; Jason Morris; Chad Crystal; Awawu Igbinadolor; Gregory Huhn; Jose Cardona; Imad Shawa; Princy Kumar; Andrew C Adams; Jacob Van Naarden; Kenneth L Custer; Michael Durante; Gerard Oakley; Andrew E Schade; Timothy R Holzer; Philip J Ebert; Richard E Higgs; Nicole L Kallewaard; Janelle Sabo; Dipak R Patel; Matan C Dabora; Paul Klekotka; Lei Shen; Daniel M Skovronsky; BLAZE-1 Investigators